Dorsomorphin (Compound C): Precision AMPK & BMP Pathway Cont

2026-04-16

Dorsomorphin (Compound C): Precision AMPK & BMP Pathway Control in Advanced Cell Signaling Workflows

Principle Overview: Mechanism and Selectivity of Dorsomorphin

Dorsomorphin, also known as Compound C, is a groundbreaking ATP-competitive AMPK inhibitor with a Ki of 109 nM (source: product_spec). Its high selectivity for AMP-activated protein kinase (AMPK) over closely related kinases such as protein kinase A, protein kinase C, and Janus kinase 3 makes it a premier choice for dissecting metabolic signaling and autophagy regulation. Mechanistically, Dorsomorphin blocks AMPK activity, leading to robust suppression of downstream events, including up to 80% inhibition of acetyl-CoA carboxylase (ACC) phosphorylation and a pronounced reduction in autophagic proteolysis (source: workflow_recommendation).

Beyond AMPK, Dorsomorphin is a potent BMP signaling inhibitor—blocking Smad 1/5/8 phosphorylation, which directly impacts cellular differentiation, neural induction, and iron metabolism modulation (source: product_spec). These dual actions underpin its widespread adoption in studies involving inhibition of AMPK activity in hepatocytes, cancer cell signaling, stem cell maintenance, and developmental biology models.

Step-by-Step Workflow: Protocol Enhancements for Reliable Results

For researchers targeting AMPK and BMP pathways, workflow precision starts with reliable solubilization and dosing. Dorsomorphin is insoluble in water and ethanol but dissolves efficiently in DMSO—achieving concentrations of ≥8.49 mg/mL with gentle warming and ultrasonic treatment (source: product_spec). Freshly prepared DMSO stocks are recommended, as solutions degrade with prolonged storage.

Protocol Parameters

AMPK inhibition in hepatocytes | 10 μM final Dorsomorphin concentration | Primary cell and immortalized hepatocyte assays | Achieves >80% reduction in ACC phosphorylation, enabling robust assessment of metabolic pathway perturbation | product_spec
DMSO stock preparation | 8.49 mg/mL (gentle warming & ultrasonic treatment) | All cell lines and in vivo injections | Ensures complete dissolution for consistent dosing and avoids precipitation artifacts | product_spec
Incubation time for pathway inhibition | 1–4 hours | Assays quantifying acute signaling changes (e.g., western blot for pAMPK/pACC, BMP4-induced SMAD phosphorylation inhibition) | Balances sufficient pathway suppression with cell viability | workflow_recommendation

For BMP pathway modulation (e.g., in neural induction or iron metabolism studies), pre-treat cells with Dorsomorphin 30–60 minutes prior to BMP4 stimulation to maximize suppression of Smad 1/5/8 phosphorylation (source: workflow_recommendation).

Key Innovation from the Reference Study

The referenced study (Patra et al., 2020) revealed that progressive rotavirus infection sharply downregulates Nrf2, the master regulator of cellular redox defense, via proteasomal degradation mechanisms. This insight highlights the intricate interplay between viral stress, redox homeostasis, and signaling cascades such as AMPK and autophagy. Practically, this guides assay design: when using Dorsomorphin to probe AMPK or autophagy’s role in redox-sensitive contexts, it is critical to monitor Nrf2 status, as pathway crosstalk or off-target stress responses can confound interpretation. Incorporating Nrf2/HO-1 readouts alongside canonical markers (e.g., pACC, LC3-II, or pSMAD) strengthens conclusions regarding Dorsomorphin’s specificity and the integrity of stress response modulation.

Advanced Applications and Comparative Advantages

1. Metabolic Pathway Dissection in Hepatocytes and Cancer Models
Dorsomorphin’s selectivity enables precise inhibition of AMPK activity in hepatocytes and tumor-derived lines (e.g., HeLa, HT-29), facilitating studies of lipid metabolism, glucose uptake, and cell survival (source: product_spec). Its reversible action allows for kinetic profiling of metabolic flux and recovery post-inhibitor washout.

2. Autophagy Regulation and Mitochondrial Quality Control
By inhibiting AMPK, Dorsomorphin suppresses autophagic proteolysis, making it a key tool in dissecting the relationship between energy sensing, mitochondrial turnover, and cell fate decisions in both homeostatic and pathological states (source: workflow_recommendation).

3. BMP4-Induced SMAD Phosphorylation Inhibition and Differentiation Control
In human embryonic stem cell models, Dorsomorphin blocks BMP4-induced SMAD1/5/8 phosphorylation, promoting neural induction and self-renewal. This property is invaluable for studies on developmental patterning and regenerative medicine (source: product_spec).

4. Iron Metabolism Modulation
Animal studies confirm that Dorsomorphin’s inhibition of hepatic BMP signaling reduces hepcidin transcription, elevating serum iron—offering a pharmacological entry point into iron homeostasis research (source: product_spec).

Troubleshooting & Optimization Tips

Solubility Issues: If cloudiness or precipitation occurs after DMSO dilution, re-warm and sonicate. Never use water or ethanol as solvents for Dorsomorphin.
Batch Variability: Always verify compound identity with supplier documentation. APExBIO’s Dorsomorphin (Compound C) undergoes stringent QC for batch-to-batch consistency (source: product_spec).
Off-Target Effects: Employ dose-response curves and include vehicle controls (DMSO only). For AMPK-focused work, confirm specificity using downstream targets (pACC) and control kinases (e.g., pPKA).
Storage and Stability: Store solid Dorsomorphin at -20°C. Prepare working solutions fresh; avoid repeated freeze-thaw cycles, as solutions are not recommended for long-term storage (source: product_spec).
Interpreting Redox-Linked Results: Given the crosstalk with Nrf2, always monitor redox-sensitive markers when exploring autophagy or stress response outcomes, as highlighted in the rotavirus-Nrf2 study (Patra et al., 2020).

Why this cross-domain matters, maturity, and limitations

The link between AMPK/autophagy modulation and redox homeostasis, as uncovered by the reference study, underscores the necessity of integrated pathway analysis. For example, Dorsomorphin-driven inhibition of AMPK in the context of viral infection or oxidative stress may inadvertently affect Nrf2 stability and downstream antioxidant defenses, potentially confounding experimental outcomes. While Dorsomorphin remains a gold standard for metabolic and BMP pathway interrogation, its use in infection or redox studies requires careful parallel monitoring of Nrf2/HO-1 and related targets (source: Patra et al., 2020). Maturity: While robust in metabolic and developmental models, the compound’s suitability for direct antiviral/redox applications is still under investigation—interpret results with appropriate controls.

Future Outlook: Implications and Considerations

With its dual-action profile and well-characterized selectivity, Dorsomorphin (Compound C) from APExBIO is poised to remain indispensable for dissecting AMPK- and BMP-linked pathways in both basic and translational research. The growing appreciation of pathway crosstalk, as underlined by the Nrf2-rotavirus study, will drive adoption of multiplexed readouts and more nuanced experimental designs. Researchers are encouraged to leverage Dorsomorphin in concert with real-time redox and signaling markers to unravel the complexity of cellular adaptation and stress.

For detailed protocols, QC documentation, and to order, visit the Dorsomorphin (Compound C) product page at APExBIO.